Hoffman K, Videan E N, Fritz J, Murphy J
Primate Foundation of Arizona, P.O. Box 20027, Mesa, AZ 85277-0027, USA.
Ann N Y Acad Sci. 2007 Sep;1111:404-10. doi: 10.1196/annals.1406.018. Epub 2007 Feb 15.
We report here the first documented case of ocular coccidioidomycosis in a chimpanzee (Pan troglodytes). In 1996, a 12-year-old female chimpanzee was undergoing treatment with an experimental triazole, BayR3783, for coccidioidomycosis when she was diagnosed with severe conjunctivitis in the right eye. Subsequent development of a coccidioidal granuloma of the ventral conjunctiva and anterior uvea was noted over the next several months, distorting the lens, iris, pupil, and sclera and progressing to uveitis. Treatment with BayR3783 and subconjunctival injections of triamcinolone were successful in reducing the ocular mass, but extensive damage was done to the lens and cornea. This case study provides an interesting comparison to ocular coccidioidomycosis cases observed in both humans and canines.
我们在此报告首例有记录的黑猩猩(Pan troglodytes)眼部球孢子菌病病例。1996年,一只12岁的雌性黑猩猩正在接受实验性三唑类药物BayR3783治疗球孢子菌病,此时被诊断出右眼患有严重结膜炎。在接下来的几个月里,观察到腹侧结膜和前葡萄膜出现球孢子菌性肉芽肿,使晶状体、虹膜、瞳孔和巩膜变形,并发展为葡萄膜炎。使用BayR3783治疗以及结膜下注射曲安奈德成功减轻了眼部肿物,但晶状体和角膜受到了广泛损害。本病例研究为人类和犬类中观察到的眼部球孢子菌病病例提供了有趣的对比。